Investment in African health-tech start-ups reached $103m in 2020, almost four times the 2019 level, while biotech investment also climbed, according to the 2021 Africa Risk Reward Index published this week by Control Risks and Oxford Economics Africa.
Developing capacity in Africa would likely make vaccines cheaper due to reduced import tariffs, taxes and transport costs, the report says. “The
Understand Africa's tomorrow... today
Get full access to The Africa Report